Impact of Clomiphene Citrate Administration During the Early Luteal Phase on Endocrine Profile in IVF Cycles (CLOFA)

F

Fundació Privada Eugin

Status and phase

Completed
Phase 4

Conditions

Female Infertility

Treatments

Drug: Clomifene Citrate

Study type

Interventional

Funder types

Other

Identifiers

NCT01791751
CLOFA
2011-002173-33 (EudraCT Number)

Details and patient eligibility

About

The purpose of this study is to evaluate the effect on LH levels of the 5-day CC administration during luteal phase in oocyte donors, to investigate whether the CC corrects the suppressed LH levels in the luteal phase and whether it prolongs the luteal phase in the agonist triggered antagonist cycles.

Enrollment

10 patients

Sex

Female

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Oocyte donors
  • 18-35 years old
  • BMI 18-29 Kg/m2
  • Normal basal hormonal levels
  • No contraceptive pill

Exclusion criteria

  • Polycystic ovarian syndrome (PCOS)
  • Previous participation in the study

Trial design

10 participants in 2 patient groups

Clomifene Citrate
Experimental group
Description:
Clomifene Citrate 50 mg
Treatment:
Drug: Clomifene Citrate
Control
No Intervention group
Description:
No intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems